Cassava Sciences | PTIE - Attività





Attività Cambiamento Data
Abbott USD 110.43B 23.72B 2026-03
Amgen USD 95.64B 3.14B 2026-06
Biogen USD 32.09B 2.6B 2026-06
Cara Therapeutics USD 25.82M 6.26M 2026-03
Cassava Sciences USD 108.37M 9.99M 2026-03
Eisai JPY 1.56T 108.98B 2026-06
Eli Lilly USD 142.28B 25.71B 2026-06
Geron USD 519.01M 15.11M 2026-06
J&J USD 201.06B 167M 2026-06
Merck USD 129.8B 1.12B 2026-06
Novartis USD 122.03B 3.5B 2026-06
Novavax USD 955.58M 87.59M 2026-06
Pfizer USD 201.13B 6.49B 2026-06
Roche Holding CHF 98.2B 2.5B 2026-06